Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
With the ongoing utilization and promise of contrast-enhanced mammography (CEM) to help assess tumoral neovascularization, researchers have also noted challenges with the imaging modality.
Accordingly, in a poster presentation at the European Congress of Radiology, researchers discussed key limitations as well as artifacts that can occur on CEM. Here are a few takeaways from their research.
1. Emphasizing that nipple enhancement artifacts tend to be asymmetrical in nature, the poster authors suggested using low-energy (LE) images to help differentiate between artifactual enhancement and pathologically thickened skin. They also noted that ultrasound can be beneficial in recognizing artifactual nipple enhancement caused by positioning issues.
2. The researchers cautioned that drops of contrast may mimic calcifications on CEM. However, they noted that actual calcifications will be black on recombined (RE) images whereas contrast agent will show up as white on LE and RE images.
While contrast-enhanced mammography revealed no pathological mass or non-mass enhancement, subsequent ultrasound imaging led to a confirming biopsy diagnosing invasive lobular carcinoma. (Images courtesy of the European Congress of Radiology.)
3. Premature breast compression may cause venous contrast retention and subsequent intensity in vascular opacification, according to the poster authors. They noted that resulting dense linear opacities corresponding to vascular structures may appear on initial LE and RE image acquisitions. If the dense linear opacities are still appearing on the last images acquired, the authors said one should suspect venous occlusion.
4. Due to weak enhancement on CEM, the poster authors noted that it may be difficult to differentiate some malignancies, such as invasive lobular carcinoma, papillary carcinoma, and mucinous carcinoma, from background parenchymal enhancement (BPE). For these challenging cases, they emphasized subsequent ultrasound imaging.
5. The combination of thick peripheral enhancement with a central or partial negative contrast enhancement (NCE) sign may occur with benign and malignant breast lesions, according to the poster authors. They pointed out that mucinous carcinoma may have low visibility on RE views and can be confused with pseudocystic lesions.
Reference
1. Constantin IL, Harguem S, Arfi-Rouche J, Baileyguier C. Contrast-enhanced mammography — artifacts and pitfalls. Presented at the European Congress of Radiology, February 28-March 3, 2024, Vienna, Austria. https://www.myesr.org/congress/
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
What New Research Reveals About Novice Use of AI-Guided Cardiac Ultrasound
April 4th 2025In a study recently presented at the American College of Cardiology (ACC) conference, researchers found that novice use of AI-guided cardiac ultrasound after an AI-enabled electrocardiogram increased the positive predictive value for reduced left ventricular ejection fraction (LVEF) or aortic valve stenosis by 33 percent.